A proposal to let couples select embryos for disease resistance and intelligence has renewed debate over reproductive choice, disability rights, and genetic inequality.
The argument supports broader use of embryo screening during in vitro fertilization, or IVF. Yet it joins two very different goals. Avoiding a serious inherited illness is more established. Predicting a future child’s intelligence is far less certain.
“Couples should be allowed to select embryos on the basis of both disease resistance and IQ.”
That position gives parents wide control over reproductive decisions. Critics counter that such freedom may affect children, families, and society long after an embryo is selected.
Disease Screening Already Has a Role
Fertility clinics can test embryos for some genetic changes linked to serious disorders. The process is known as preimplantation genetic testing.
This testing may help families avoid passing on conditions caused by a specific gene variant. Examples can include cystic fibrosis, Huntington’s disease, and sickle cell disease.
Even these decisions can be difficult. A genetic variant may produce different symptoms among patients. Tests may also identify risk rather than certainty.
Supporters say parents should be able to reduce preventable suffering. They view embryo screening as another form of reproductive medicine, especially for families with known genetic histories.
Disability advocates often offer a different view. Some warn that screening can imply that lives with disabilities are less valuable. They also argue that health policy should support people who are living with genetic conditions, not focus only on preventing births.
IQ Prediction Faces Scientific Limits
Selecting for IQ presents a much harder scientific problem. Intelligence is influenced by many genetic variants, each usually linked to a tiny statistical effect.
Education, nutrition, health, family life, pollution, stress, and economic security also shape cognitive development. A genetic score cannot account for a child’s full future.
Embryo selection creates another limit. Parents can choose only among the embryos produced during one IVF cycle. Siblings share much of their DNA, so predicted differences may be modest.
Key concerns include:
- Scores may perform less accurately across ancestry groups.
- A variant associated with one trait may affect other traits.
- Predictions describe probabilities, not guaranteed outcomes.
- IVF and genetic testing can be costly and physically demanding.
The label “IQ selection” may therefore promise more precision than current science can deliver. Genetics is not a restaurant menu, however much a sales brochure might suggest otherwise.
Choice Could Deepen Social Divides
Supporters of parental choice may argue that governments should not decide which health benefits families can pursue. If testing is safe and accurate, they ask why parents should be barred from using it.
Opponents worry that access would depend heavily on wealth. Affluent families could gain first access to embryo ranking services, while others could not afford routine fertility care.
There is also concern about pressure. A choice offered to parents can slowly become an expectation imposed on them. Insurers, clinics, schools, or relatives might influence decisions that should remain private.
Regulation differs across countries. Some systems permit embryo testing mainly for serious medical conditions. Others give clinics and patients more discretion. Adding intelligence predictions would force regulators to define acceptable traits and acceptable levels of evidence.
Policy Must Separate Treatment From Enhancement
The central policy error would be treating disease resistance and IQ as equally measurable outcomes. They carry different evidence, risks, and social consequences.
Any rule should require clear proof of clinical value, honest explanations of uncertainty, privacy protections, and independent oversight. Marketing claims also need scrutiny, especially when companies convert population research into promises about individual children.
Embryo screening may help some families reduce the risk of severe disease. That does not make reliable selection for intelligence a settled medical service.
The next stage of the debate should focus less on whether parents want healthy, successful children. Most do. The harder questions concern scientific accuracy, fair access, and the limits society places on turning uncertain predictions into reproductive decisions.
